More Business Wire
View Older Stories View Newer Stories-
Piedmont Lithium Reports Q3 2024 Results
-
Schrödinger Reports Third Quarter 2024 Financial Results
-
Blackstone Secured Lending Fund Reports Third Quarter 2024 Results
-
NuScale Power to Participate in Upcoming Investor Conferences
-
Pentair to Attend the Baird Global Industrial Conference
-
TheracosBio is a Proud Sponsor of the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
-
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
-
KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Ple
-
Kolibri Global Energy Inc. Announces Alicia Renee Well Pad Producing Over 2,800 BOEPD
-
Lazard Reports October 2024 Assets Under Management
-
GrafTech Reports Third Quarter 2024 Results
-
GrafTech Announces Agreement for New Capital to Bolster Liquidity
-
State Grid Zhenjiang Power Supply Company Leads in Publishing China's First National Standard for "Technical Guidelines for Emergency Supplies for Electrochemical Energy Storage Stations&quo
-
Monterubello, Ermenegildo Zegna Group’s Controlling Shareholder, Purchased 913,000 Shares and Intends to Acquire Additional 2 Million Shares
-
Sila Realty Trust Announces Third Quarter 2024 Results
-
Sea Limited Reports Third Quarter 2024 Results
-
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates
-
Chase Sapphire Lounge by The Club Expands Airport Lounges to Phoenix, San Diego and Beyond
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
-
Trane Technologies and Autodesk Collaborate to Accelerate and Simplify Sustainable Building Design
-
ITT Releases 2024 Sustainability Report; Demonstrates Continued Progress Towards Environmental and Social Targets While Continuing Best-in-Class Governance Practices
-
VX4 Achieves Major Milestone With Launch of Phase 2 of Piloted Flight Testing
-
NW Natural Holdings Reports Strong Third Quarter 2024 Results
-
Blue Point’s Pinnacle MEP Expands Indiana Presence with Bell Plumbing Services Add-On
-
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
-
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
-
McKay Brothers Receives Minority Investment from Citadel Securities
-
Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter
-
Immersive Labs Unveils GenAI-Powered Cyber Exercise Creator to Rapidly Prepare Workforces for Threats
-
ACA Group Acquires Financial Compliance Firm, FINOP Consulting
-
Vertical Aerospace Launches "Flightpath 2030", a Strategy to Pioneer Electric Aviation
-
American Strategic Investment Co. Announces Third Quarter 2024 Results
-
Cyware Achieves FedRAMP® Ready Status to Advance State-of-the-Art Cyber Intelligence Exchange Across U.S. Federal Agencies
-
Visa Flexible Credential Goes Global: Transforming the Card for a Digital Future
-
Samsara Unveils Latest Product Innovations and Strategic Partnership at Go Beyond ‘24
-
Kennedy Wilson Originates $175 Million Construction Loan for Artwalk Towers in Jersey City, NJ
-
Jumio Announces Mike Nawrocki as Chief Revenue Officer
-
Semarchy and Apgar Partner to Streamline SAP S/4HANA Migrations with New SAP Accelerators
-
Centex Construction Appoints Jeff Wonsmos as Chief Financial Officer
-
Carta Announces Exclusive Streamlined Solution With Morgan Stanley at Work for Private Companies Seeking to IPO
-
Visa Recognizes Creators as Small Businesses
-
Netcracker Receives 2024 NaaS Excellence Award for Most Impactful Service Automation Vendor
-
Sound Growth Partners Invests in LPi
-
Ohmium, Spirare Energy, and JNCASR Collaborate on India’s First CO2 to Green Methanol Plant
-
Mursla Bio Joins Leading European Consortium to Advance Clinical Applications Based on Extracellular Vesicle Science
-
Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
-
IND for ATA-200, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5), cleared to proceed by FDA
-
intoPIX and Media Links: Powering Next-Generation IP Media Transport with JPEG XS at InterBEE 2024
-
GMO GlobalSign Renews its Status with G-Cloud
-
On Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
